Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.04 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Can AI Drive Peloton's Comeback? ↗

November 18, 2025

The market is hopping with interesting news.

Via The Motley Fool

Topics Artificial Intelligence

Curious about the most active S&P500 stocks in today's session? ↗

November 18, 2025

Stay informed about the most active stocks in the S&P500 index on Tuesday's session. Discover the stocks that are generating the highest trading volume and driving market activity.

Via Chartmill

Markets Brace for Impact: A Deep Dive into the Global "Risk-Off" Mood

November 18, 2025

Global financial markets are currently gripped by a palpable "risk-off" sentiment, sending investors scurrying away from speculative assets and towards the perceived safety of traditional havens. This...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Are US Equity Valuations on Shaky Ground? Market Downturn Sparks Sustainability Concerns

November 18, 2025

The U.S. stock market is currently navigating a turbulent period, marked by a palpable sense of unease regarding the sustainability of elevated equity valuations. As of November 2025, investors are...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Bitcoin's Sub-$90,000 Dip Signals Broader Market Caution

November 18, 2025

Bitcoin (BTC) recently experienced a significant dip below the $90,000 threshold, a move that has sent ripples through the cryptocurrency market and appears to be closely correlated with a wider...

Via MarketMinute

Topics Bonds ETFs Economy

2 No-Brainer Healthcare Stocks to Buy Now ↗

November 18, 2025

These two healthcare stocks scan as bargains right now.

Via The Motley Fool

Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Pfizer (NYSE:PFE)

November 17, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy? ↗

November 17, 2025

Pfizer's weight management pipeline just got a boost.

Via The Motley Fool

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. ↗

November 17, 2025

Looking for the most active stocks in the S&P500 index on Monday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

Via Chartmill

Valuation Fears Ignite "Great Rotation" in Global Markets as Investors Seek Shelter from Elevated Prices

November 17, 2025

Global financial markets are currently gripped by a palpable sense of unease, as elevated valuations, particularly within the high-flying technology and Artificial Intelligence (AI) sectors, spark...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Novo Nordisk's New Chair Aims To Reinforce Board As Foundation Tightens Control ↗

November 17, 2025

Novo Nordisk's new chair Lars Sorensen plans to add pharma expertise and address governance concerns after a major board overhaul backed by the company's foundation.

Via Benzinga

2 Giant Healthcare Stocks to Buy Hand Over Fist in November ↗

November 17, 2025

Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive healthcare investments in November.

Via The Motley Fool

Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment ↗

November 17, 2025

Johnson & Johnson said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics.

Via Investor's Business Daily

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗

November 17, 2025

Healthcare stocks have far outperformed the broader market over the past month.

Via The Motley Fool

Topics ETFs Government World Trade

Down 55%, Should You Buy the Dip on Pfizer? ↗

November 17, 2025

Pfizer is a pharmaceutical industry giant facing normal pharmaceutical industry headwinds; it will survive.

Via The Motley Fool

Topics Intellectual Property

Michael Burry Bets Against Nvidia and Palantir. But It's Not What You Think. ↗

November 16, 2025

Burry bought $1.1 billion of put options in these stocks.

Via The Motley Fool

Topics Artificial Intelligence

Is Pfizer Stock a Buy After This $10 Billion Acquisition? ↗

November 15, 2025

The company has been on an acquisition spree for years, and this one may be the most important yet.

Via The Motley Fool

Topics Intellectual Property Lawsuit

Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty

November 14, 2025

As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market ↗

November 14, 2025

Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com and TuneIn.

Via Benzinga

Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗

November 14, 2025

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

Via Benzinga

Topics Artificial Intelligence

AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines

November 14, 2025

The pharmaceutical industry is on the cusp of a profound transformation, driven by the integration of data science and Artificial Intelligence (AI) into drug formulation stability models. This...

Via TokenRing AI

Topics Artificial Intelligence Economy Product Recall

AI Revolutionizes Medicine: Precision Bioanalysis and Targeted Delivery Usher in a New Era of Healthcare

November 14, 2025

The convergence of artificial intelligence (AI) with advanced bioanalysis and targeted drug delivery technologies is fundamentally reshaping the landscape of medicine and healthcare. These synergistic...

Via TokenRing AI

Topics Artificial Intelligence

What's going on in today's session: S&P500 most active stocks ↗

November 14, 2025

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for...

Via Chartmill

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since ↗

November 14, 2025

Via MarketBeat

Why Pfizer (PFE) Shares Are Sliding Today

November 14, 2025

Shares of global pharmaceutical company Pfizer (NYSE:PFE) fell 2.5% in the morning session after the company cut its stake in its pandemic partner BioNTech by more than half, a move that overshadowed...

Via StockStory

Topics Artificial Intelligence Stocks Supply Chain

Ozempic Maker Novo Nordisk Faces Board Shakeup ↗

November 14, 2025

Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market.

Via Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗

November 14, 2025

Via Benzinga

Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO ↗

November 14, 2025

The board overhaul follows mass resignations triggered by internal disputes over Novo’s direction.

Via Stocktwits

Pfizer Stock Slips Premarket Despite Completing Metsera Deal; Investors React To BioNTech Stake Cut ↗

November 14, 2025

The Metsera buyout brings multiple obesity and cardiometabolic drug candidates into Pfizer’s pipeline, including a GLP-1 nearing Phase 3.

Via Stocktwits

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions